© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients1
Department of Medicina Sperimentale e Clinica G. Salvatore, University of Catanzaro, Catanzaro, Italy
* Corresponding author. Tel.: +39-961-712-264; fax: +39-961-775-373; e-mail: perticone@unicz.thebrain.net
Objective: To examine whether middle (two months) and long-term (six months) isradipine sustained-release treatment improves endothelium-dependent vasodilation in never treated hypertensive patients. Methods: The responses of the forearm vasculature to acetylcholine (7.5, 15 and 30 µg/min) and sodium nitroprusside (0.8, 1.6, 3.2 µg/min) were evaluated in 12 normotensive controls (seven men and five women, aged 25 to 49 years), and in 12 hypertensives (eight men and four women, aged 20 to 47 years) at baseline and after two and six months of isradipine sustained-release treatment. Drugs were infused into the brachial artery, and forearm blood flow was measured by strain-gauge plethysmography. Results: At baseline, the response to acetylcholine was significantly lower in hypertensives vs controls: at the highest dose (30 µg/min), forearm blood flow was 28.6±2.4 ml/100 ml of tissue per min in the controls vs 8.9±1.0 ml/100 ml of tissue per min in hypertensives (p<0.0001). Similarly, vascular resistance was significantly (p<0.0001) higher in hypertensives: 4.8±0.5 units (controls) vs 15.1±1.7 units (hypertensives). After isradipine treatment, the forearm blood flow in hypertensive patients changed from 8.9±1.0 ml/100 ml of tissue per min to 16.0±1.2 ml/100 ml of tissue per min (two months; p<0.0001) and 15.2±1.4 ml/100 ml of tissue per min (six months; p<0.0001). Isradipine treatment did not modify the vasodilating effect of sodium nitroprusside. Conclusions: Our data demonstrate for the first time that the calcium antagonist isradipine improves acetylcholine-induced vasodilation in hypertensives.
KEYWORDS Calcium channel blocker; Acetylcholine; Endothelium; Hypertension; Isradipine; Antihypertensive therapy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Ridderstrale, E. Ulfhammer, S. Jern, and T. Hrafnkelsdottir Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy Hypertension, April 1, 2006; 47(4): 686 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ceravolo, R. Maio, A. Pujia, A. Sciacqua, G. Ventura, M. C. Costa, G. Sesti, and F. Perticone Pulse pressure and endothelial dysfunction in never-treated hypertensive patients J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1753 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Perticone, R. Ceravolo, A. Pujia, G. Ventura, S. Iacopino, A. Scozzafava, A. Ferraro, M. Chello, P. Mastroroberto, P. Verdecchia, et al. Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients Circulation, July 10, 2001; 104(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Geiger, A.-P. Zou, W. B. Campbell, and P.-L. Li Inhibition of cADP-Ribose Formation Produces Vasodilation in Bovine Coronary Arteries Hypertension, January 1, 2000; 35(1): 397 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perticone, R. Maio, R. Ceravolo, C. Cosco, C. Cloro, and P. L. Mattioli Relationship Between Left Ventricular Mass and Endothelium-Dependent Vasodilation in Never-Treated Hypertensive Patients Circulation, April 20, 1999; 99(15): 1991 - 1996. [Abstract] [Full Text] [PDF]
|
|